184 related items for PubMed ID: 12324672
1. Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma.
Currie GP, Fowler SJ, Wilson AM, Sims EJ, Orr LC, Lipworth BJ.
Thorax; 2002 Oct; 57(10):865-8. PubMed ID: 12324672
[Abstract] [Full Text] [Related]
2. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
4. Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness.
Langley SJ, Holden J, Derham A, Hedgeland P, Sharma RK, Woodcock A.
Chest; 2002 Sep; 122(3):806-11. PubMed ID: 12226017
[Abstract] [Full Text] [Related]
5. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M, Wettenger R, Gans SJ.
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[Abstract] [Full Text] [Related]
6. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
7. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
8. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
Thongngarm T, Silkoff PE, Kossack WS, Nelson HS.
J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934
[Abstract] [Full Text] [Related]
9. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
Leach CL, Kuehl PJ, Chand R, Ketai L, Norenberg JP, McDonald JD.
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
[Abstract] [Full Text] [Related]
10. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
Colice G, Martin RJ, Israel E, Roche N, Barnes N, Burden A, Polos P, Dorinsky P, Hillyer EV, Lee AJ, Chisholm A, von Ziegenweidt J, Barion F, Price D.
J Allergy Clin Immunol; 2013 Jul; 132(1):45-54. PubMed ID: 23591272
[Abstract] [Full Text] [Related]
11. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study.
Corda L, Gardenghi GG, Modina D, Montemurro LT, Novali M, Tantucci C.
Allergy Asthma Proc; 2011 Jul; 32(6):29-34. PubMed ID: 22221427
[Abstract] [Full Text] [Related]
12. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
[Abstract] [Full Text] [Related]
13. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
[Abstract] [Full Text] [Related]
14. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
[Abstract] [Full Text] [Related]
15. A comparison of 2 extrafine hydrofluoroalkane-134a-beclomethasone formulations on methacholine hyperresponsiveness.
Fardon TC, Burns P, Barnes ML, Lipworth BJ.
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):422-30. PubMed ID: 16597076
[Abstract] [Full Text] [Related]
16. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
Currie GP, Stenback S, Lipworth BJ.
Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770
[Abstract] [Full Text] [Related]
17. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
Lumry WR, Conway MM, LaForce CF, Pearlman DS, Scott CA, Herje NE, Wu WW, Crim C.
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
[Abstract] [Full Text] [Related]
18. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD, Walters EG.
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[Abstract] [Full Text] [Related]
19. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
Perruchoud AP, Lundback B, Yigla M, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
[Abstract] [Full Text] [Related]
20. Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate.
Fowler SJ, Orr LC, Sims EJ, Wilson AM, Currie GP, McFarlane L, Lipworth BJ.
Chest; 2002 Aug; 122(2):618-23. PubMed ID: 12171841
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
